Public Health Archives - Page 13 of 34

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

September 17, 2025

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

September 15, 2025

Takeda Appoints Rhonda Pacheco to Lead U.S. Business Unit as Julie Kim Prepares for CEO Role

September 11, 2025

THIS WEEK'S STORIES

Apollo Therapeutics Reports Positive Phase 2a Results for Camoteskimab in Atopic Dermatitis

September 16, 2025

Southlake Health Adopts Philips AI-Enabled MRI to Expand Diagnostic Imaging Capacity and Improve Patient Experience

September 17, 2025

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

September 17, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

Phreesia Partners with Sesame Workshop to Promote Children’s Health Through Sesame Street

Washington Trust Wins Exemplary Worksite Health Award for Ninth Consecutive Year

Nearly Half of Americans Delay Healthcare Due to Cost and Insurance Barriers, Madaket Health Survey Finds

Majority of Americans Support Water Fluoridation, New Survey Finds

Stronger Gun Laws Linked to Fewer Firearm Suicides, While Socioeconomic Factors Drive Homicides, Northwell Health Study Finds

Most Read

Hallmark Health Care Solutions Names John Feminella Senior Vice President of Data and AI

Sunflower Therapeutics Reaches First Milestone in HPV Vaccine Collaboration with SK bioscience

Brainlab Wins FDA Clearance and Launches Spine Mixed Reality Navigation in the U.S.

Vertex Secures CASGEVY Reimbursement Agreement in Italy for Beta Thalassemia and Sickle Cell Disease

EDITOR PICKS

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

Takeda Appoints Rhonda Pacheco to Lead U.S. Business Unit as Julie Kim Prepares for CEO Role

THIS WEEK'S STORIES

Apollo Therapeutics Reports Positive Phase 2a Results for Camoteskimab in Atopic Dermatitis

Southlake Health Adopts Philips AI-Enabled MRI to Expand Diagnostic Imaging Capacity and Improve Patient Experience

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

POPULAR CATEGORY

ABOUT US

FOLLOW US